In another mouse model, symptoms of cardiomyopathy due to DN-POLG transgene expression were confirmed (54), and in another model, DN-POLG transgene expression led to left ventricle hypertrophy that progressed into cardiogenic heart failure (55). The gene discussed is POLG; the disease is cardiomyopathy.